Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2006 Jan 19;107(10):4063–4070. doi: 10.1182/blood-2005-09-3870

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2006, The American Society of Hematology

PMC Copyright notice

Figure 5. — PS-341 does not worsen the myelosuppressive effect of 153-Sm-EDTMP. Blood cell counts in treatment groups bearing 5TGM1-myeloma platelets (A), hemoglobin (B), and white blood cells (C) were monitored on days 12, 21, 25, and 32. Error bars represent the mean ± SD from the counts of 6 mice in each group. (D) Clonogenic assay with enriched hematopoietic progenitor cells from normal mice receiving PS-341 and/or 153-Sm-EDTMP. Data represent relative colony number (CFU-GEMM, CFU-GM, BFU-E, BFU-MK) expressed as a percentage of colony counts in control non–tumor-bearing mice. Bars indicate SD.